Trials / Unknown
UnknownNCT03333499
the Effects of YangXinShi (YXS) on the Quality of Life and Exercise Tolerance in Patients With Chronic Heart Failure
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Dalian University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators set out to evaluate the effects of the traditional Chinese medicinal mixture under the brand name YangXinShi (YXS) on the prognosis in patients with chronic heart failure when it is combined with the optimal combination drug treatment of heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YanXinShi placebo pills | participants will take matched 1800 mg YXS placebo pills TID in addition to the optimal combination drug treatment of heart failure |
| DRUG | YanXinShi pills | participants will take 1800 mg YXS pills TID in addition to the optimal combination drug treatment of heart failure |
| DRUG | Trimetazidine pills | participants will take 20mg Trimetazidine pills TID in addition to the optimal combination drug treatment of heart failure |
| DRUG | YanXinShi and Trimetazidine pills | participants will take 1800 mg YXS and 20 mg Trimetazidine pills TID in addition to the optimal combination drug treatment of heart failure |
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2017-11-07
- Last updated
- 2017-11-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03333499. Inclusion in this directory is not an endorsement.